Hannah Joseph

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0JVH01012
  • NSEID:
  • BSEID: 544687
INR
104.00
0.5 (0.48%)
BSENSE

Jun 11, 11:03 AM

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.0 k (-62.96%) Volume

Shareholding (Feb 2026)

FII

2.39%

Held by 2 FIIs

DII

10.15%

Held by 0 DIIs

Promoter

68.83%

Why is Hannah Joseph Hospital Ltd falling/rising?

11-Jun-2026

As of 10-Jun, the stock price of Hannah Joseph Hospital Ltd is rising to 103.50, driven by strong relative performance and trading above key moving averages. Despite a decline in investor participation, the stock remains liquid and is close to its 52-week high.

As of 10-Jun, the stock price of Hannah Joseph Hospital Ltd is rising, currently at 103.50, reflecting a change of 0.5 (0.49%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 1.45% today, indicating strong relative performance. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is often seen as a bullish signal for investors. <BR><BR>Moreover, the stock is close to its 52-week high, being only 4.82% away from the high of Rs 109. Despite a recent decline in investor participation, with delivery volume falling by 80.45% against the 5-day average, the stock remains liquid enough for trading, suggesting that there is still interest in the stock despite the drop in volume. Overall, these factors contribute to the upward movement of the stock price.

View full answer

Which are the latest news on Hannah Joseph?

10-Jun-2026

When is the next results date for Hannah Joseph Hospital Ltd?

19-May-2026

The next results date for Hannah Joseph Hospital Ltd is 29 May 2026.

The next results date for Hannah Joseph Hospital Ltd is scheduled for 29 May 2026.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 236 Cr (Micro Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

11.48%

stock-summary
Price to Book

2.42

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
80.9%
0%
80.9%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Hannah Joseph for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Statement On Deviation Or Variation For Proceeds Of Public Issue

29-May-2026 | Source : BSE

Statement on deviation or variation for half year ended 31.03.2026

Corporate Action-Board approves Dividend

29-May-2026 | Source : BSE

We wish to inform you that the Board of Directors of the Company at their meeting held on 29.05.2026 has recommended a final dividend of Rs.2/- per equity share of face value of Rs.10/- (20%) for the financial year 2025-26.

Audited Financial Results For The Half Year And Year Ended March 31 2026.

29-May-2026 | Source : BSE

Audited Financial Results for the Half year and year ended March 31 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
4.09
Debt to EBITDA (avg)
1.42
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.81
Tax Ratio
30.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.54%
ROCE (avg)
20.09%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
21
Industry P/E
0
Price to Book Value
2.42
EV to EBIT
11.91
EV to EBITDA
8.72
EV to Capital Employed
2.71
EV to Sales
2.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.75%
ROE (Latest)
11.48%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (2.39%)

Promoter with highest holding

Mosesjoseph Arunkumar . (66.8%)

Highest Public shareholder

Negen Undiscovered Value Fund (3.68%)

Individual Investors Holdings

15.79%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Hannah Joseph"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 16.36% vs 15.00% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 18.36% vs 64.10% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "49.51",
          "val2": "42.55",
          "chgp": "16.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.45",
          "val2": "11.76",
          "chgp": "14.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.36",
          "val2": "1.56",
          "chgp": "-12.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.06",
          "val2": "5.12",
          "chgp": "18.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.17%",
          "val2": "27.64%",
          "chgp": "-0.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Hannah Joseph"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 18.73% vs 22.27% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 55.06% vs 77.15% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "92.05",
          "val2": "77.53",
          "chgp": "18.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.20",
          "val2": "20.69",
          "chgp": "21.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.92",
          "val2": "3.47",
          "chgp": "-15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.18",
          "val2": "7.21",
          "chgp": "55.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.38%",
          "val2": "26.69%",
          "chgp": "0.69%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
49.51
42.55
16.36%
Operating Profit (PBDIT) excl Other Income
13.45
11.76
14.37%
Interest
1.36
1.56
-12.82%
Exceptional Items
0.00
0.00
Standalone Net Profit
6.06
5.12
18.36%
Operating Profit Margin (Excl OI)
27.17%
27.64%
-0.47%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is 16.36% vs 15.00% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is 18.36% vs 64.10% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
92.05
77.53
18.73%
Operating Profit (PBDIT) excl Other Income
25.20
20.69
21.80%
Interest
2.92
3.47
-15.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
11.18
7.21
55.06%
Operating Profit Margin (Excl OI)
27.38%
26.69%
0.69%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 18.73% vs 22.27% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 55.06% vs 77.15% in Mar 2025

stock-summaryCompany CV
About Hannah Joseph Hospital Ltd stock-summary
stock-summary
Hannah Joseph Hospital Ltd
Micro Cap
Hospital
Hannah Joseph Hospital Limited is one of the first centres in Asia to adopt DTI Fibertracking 3.0, a revolutionary navigation tool for brain tumour surgeries. To provide comprehensive range of neurosurgery and neurology services, Mosesjoseph Arunkumar established a hospital in the name of `Hannah Joseph Hospital' as a sole proprietorship in Madurai town of Tamil Nadu, in 2008.
Company Coordinates stock-summary
Icon
No Company Details Available